Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen receptors (ER), progesterone receptors (PR), and human epidermal growth factor receptor-2 (HER2) (2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.